Your browser doesn't support javascript.
loading
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
Bachelet, Delphine; Hässler, Signe; Mbogning, Cyprien; Link, Jenny; Ryner, Malin; Ramanujam, Ryan; Auer, Michael; Hyldgaard Jensen, Poul Erik; Koch-Henriksen, Nils; Warnke, Clemens; Ingenhoven, Kathleen; Buck, Dorothea; Grummel, Verena; Lawton, Andy; Donnellan, Naoimh; Hincelin-Mery, Agnès; Sikkema, Dan; Pallardy, Marc; Kieseier, Bernd; Hemmer, Bernard; Hartung, Hans Peter; Soelberg Sorensen, Per; Deisenhammer, Florian; Dönnes, Pierre; Davidson, Julie; Fogdell-Hahn, Anna; Broët, Philippe.
Affiliation
  • Bachelet D; CESP, Université Pa ris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Hässler S; CESP, Université Pa ris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Mbogning C; CESP, Université Pa ris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
  • Link J; Karolinska Institutet, Department of Clinical Neuroscience, Clinical Neuroimmunology, Stockholm, Sweden.
  • Ryner M; Karolinska Institutet, Department of Clinical Neuroscience, Clinical Neuroimmunology, Stockholm, Sweden.
  • Ramanujam R; Karolinska Institutet, Department of Clinical Neuroscience, Clinical Neuroimmunology, Stockholm, Sweden.
  • Auer M; KTH-Royal Institute of Technology, Stockholm, Sweden.
  • Hyldgaard Jensen PE; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
  • Koch-Henriksen N; Danish MS Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Warnke C; Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Ingenhoven K; Department of Clinical Epidemiology, University of Aarhus, Aarhus, Denmark.
  • Buck D; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany.
  • Grummel V; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany.
  • Lawton A; Department of Neurology, Technische Universität München, Munich, Germany.
  • Donnellan N; Department of Neurology, Technische Universität München, Munich, Germany.
  • Hincelin-Mery A; GlaxoSmithKline, Uxbridge, Middlesex, United Kingdom.
  • Sikkema D; IPSEN, Slough, Berkshire, United Kingdom.
  • Pallardy M; Sanofi, Chilly-Mazarin, France.
  • Kieseier B; GlaxoSmithKline, Uxbridge, Middlesex, United Kingdom.
  • Hemmer B; INSERM UMR 996, Univ. Paris-Sud, Faculty of Pharmacy, Université Paris-Saclay, Châtenay-Malabry, France.
  • Hartung HP; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany.
  • Soelberg Sorensen P; Department of Neurology, Technische Universität München, Munich, Germany.
  • Deisenhammer F; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Dönnes P; University of Düsseldorf, Medical Faculty, Department of Neurology, Düsseldorf, Germany.
  • Davidson J; Danish MS Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Fogdell-Hahn A; Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
  • Broët P; SciCross AB, Skövde, Sweden.
PLoS One ; 11(11): e0162752, 2016.
Article in En | MEDLINE | ID: mdl-27806057
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Anti-Idiotypic / Interferon-beta / Natalizumab / Antibodies / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Anti-Idiotypic / Interferon-beta / Natalizumab / Antibodies / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2016 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos